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Adrenocortical carcinoma (ACC) is a rare malignant neoplasm with poor prog-
nosis, which arises from adrenal cortical cells. Adrenal cancers can be classified
as functional or nonfunctional. Approximately 60% of patients with ACC present
with evidence of adrenal steroid hormone excess.
1 For non-functioning tumors,
the presentation is usually related to tumor size.
1 Patients with non-functioning
ACCs usually present with abdominal pain or pressure secondary to mass effect.
Only a few cases of spontaneously ruptured nonfunctional ACC have been
reported in the literature.
2-5 However, spontaneous rupture of a functioning ACC
has not been described.
We report a rare functioning ACC that spontaneously ruptured during work-up.
A 36-year old woman was admitted to our hospital because of a 10 kg weight
gain during the previous 5 months and a left adrenal mass incidentally detected on
abdominal ultrasonographic examination at another hospital. She had undergone
total mastectomy due to right breast cancer (stage I) 10 months before admission
and was receiving goserelin on a monthly basis. She had a moon face and a mild
buffalo hump.
The chest radiography, routine hematology and biochemistry were unremar-
kable. The endocrine examination showed elevated serum cortisol, suppressed
plasma adrenocorticotropic hormone, and loss of circadian rhythm (Table 1). The
serum cortisol level and the urinary free cortisol excretion were not reduced after
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INTRODUCTION
CASE REPORT2-mg and 8-mg dexamethasone suppression tests (Table 2). 
Magnetic resonance imaging of the abdomen revealed a
12×10.3×9.7 cm sized, heterogeneous mass in the left
adrenal gland, with possible internal hemorrhagic necrosis
(Fig. 1). Whole-body positron emission tomography/com-
puted tomography with 
18F-fluorodeoxyglucose (
18F-FDG)
images showed significant 
18F-FDG uptake in the huge left
adrenal mass and no significant uptake at any other sites. 
On the basis of the physical findings, endocrine data,
and imaging studies, the patient was diagnosed with Cush-
ing’s syndrome secondary to an ACC. We scheduled an
elective operation to remove the mass. However, the patient
complained of sudden onset of left upper quadrant abdo-
minal pain. An abdominal CT showed that the tumor mass
in the adrenal gland had increased in size and that there
was a hemorrhagic fluid collection in the left perinephric
area. These findings were suggestive of a tumor rupture
(Fig. 2). We performed a left adrenalectomy using an open
transabdominal approach. The adrenal tumor was found to
have ruptured, and the resected tumor, weighing 251 g,
was internally hemorrhagic and necrotic. Histological exa-
mination of the specimen revealed an adrenal cortical
carcinoma (Fig. 3A and B). The histological findings fulfill-
ed three of the modified Weiss’s criteria for histopatholo-
gical diagnosis of adrenocortical carcinoma with a total
score of 4 (threshold score ≥ 3):
6 The presence of ≤ 25%
clear tumor cells, the presence of necrosis, and capsular
invasion. Immunohistochemical examination showed posi-
tive labeling of neoplastic cells with synaptophysin, CD56,
alpha-inhibin, and melan-A (Fig. 3C-F), while tumor cells
did not express cytokeratin, S-100 protein, chromogranin
A, estrogen receptor, progesterone receptor, and c-erbB2
Rupture of Adrenocortical Carcinoma
Yonsei Med J   http://www.eymj.org    Volume 51   Number 6   November 2010 975
Table 1.Results of Basal Hormone Study
Hormone Data Reference range
ACTH (pg/mL)
08:00 h  7.6 6 - 60
16:00 h 3.2
24:00 h 6.7
Cortisol (µg/dL)
08:00 h 38.6 3 - 23
16:00 h 37.2
24:00 h 33.3
Plasma renin activity 0.88 0.15 - 2.33
Plasma aldosterone (ng/dL) 9.8 1 - 16
Plasma DHEA-S 669 35 - 430
Urinary free cortisol (µg/day) 883 2 - 90
Urinary VMA (mg/day) 2.3 0 - 8
Urinary metanephrine (mg/day) 0.2 0 - 1
Urinary 17-ketosteroid (mg/day) 25.8 6 - 15
ACTH, adrenocorticotropic hormone; DHEA, dehydroepiandrosterone; VMA, vanillylmandelic acid.
Table 2.Results of the Dexamethasone Suppression Test
Dexamethasone
Before 2 mg / 48 h 8 mg / 48 h
Serum cortisol (µg/dL) 38.6 33.8 35.6
Urinary free cortisol (µg/day) 883 948 1,613
Fig. 1. (A) Adrenal T1 MRI showed an approximately 12×10.3×9.7 cm,
relatively well-marginated left adrenal mass with central high signal intensity,
suggesting an internal hemorrhage. (B) Gadolinium injection revealed
heterogeneous enhancement on delayed phase.
Fig. 2. Abdominal CT showed a 14×12×10 cm sized, heterogeneously
enhancing tumor mass (A) and a hemorrhagic fluid collection around the left
kidney (B). 
AB
AB(not shown). The patient was classified with more than
stage III due to tumor spillage according to the European
Network for the Study of Adrenal Tumors (ENSAT) stag-
ing classification.
7
Replacement therapy with hydrocortisone (20-mg) was
initiated, and the patient received adjunctive chemotherapy
(cyclophosphamide, vincristine, and dacarbazine). How-
ever, the 3-month follow-up abdominal CT demonstrated a
recurred lesion in the left perirenal area. Therefore, the
patient was started on adjuvant chemotherapy, including
etoposide, doxorubicin, and cisplatin.
ACC is a rare malignancy, with an annual incidence of
approximately 1-2 persons per one million people.
8 ACCs
can be classified as functional when their hormonal secre-
tions result in clinical manifestations such as Cushing
syndrome, virilization syndrome, feminization syndrome,
or a mixed Cushing-virilizing syndrome. Tumors are con-
sidered nonfunctional when the tumors do not secrete
excessive hormones or produce hormones in quantities
sufficient to result in clinical consequences.
1,8 Patients with
nonfunctioning tumors usually present with abdominal
pain or pressure secondary to the mass effect of the large
tumor. Approximately 60 percent of ACCs are functioning
tumors, with excessive cortisol secretion seen in approxi-
mately 30% of functioning tumors: androgen hyperse-
cretion in 20%, estrogen hypersecretion in 10%, and aldos-
terone hypersecretion in 2%.
1,8 Thirty-five percent of func-
tioning ACCs secrete multiple hormones. Because many
steroid enzymes are defective in the setting of ACC, which
leads to inefficient steroid production, several steroids are
elevated in Cushing’s syndrome due to functioning ACC,
including dehydroepiandrosterone (DHEA) and its sulfate
derivative DHEA-S as well as urinary 17-ketosteroid and
17-hydroxycorticosteroids. Thus, a high serum DHEA-S
concentration is suggestive of ACC, whereas a low serum
DHEA-S concentration is suggestive of a benign adeno-
ma.
9 In the current case, the serum ACTH was reduced, the
serum cortisol level and urinary free cortisol excretion
were not suppressed after 2-mg and 8-mg dexamethasone
suppression tests, and the serum DHEA-S and urinary 17-
KS concentrations were high. Thus, endocrine data were
consistent with Cushing syndrome associated with ACC. 
Tumor rupture is a rare event.
2 To date, spontaneous
retroperitoneal hemorrhages have been reported as the pre-
valent presentation in other adrenal tumors, such as metas-
tases, adenoma, myelolipoma, and pheochromocytoma.
10,11
Only several cases of a spontaneous rupture of nonfunctio-
nal ACCs have been reported in the literature.
2,5 However,
to our knowledge, spontaneous ruptures of a functional
ACC have not been described before. The cause of ACC
ruptures is unknown. It may be related to tumor size,
necrosis caused by rapid tumor growth, rapid expansion of
the tumor secondary to an internal hemorrhage, and delay
in diagnosis.
2,5 Similarly, in some cases of the rupture of
nonfunctioning adrenal adenoma, the tumor was large in
size despite being a benign tumor.
12,13 Often, the general
health of patients with nonfunctional ACC is preserved,
except at a very late stage, leading to a delay in diagnosis.
14,15
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Fig. 3.(A) The tumor cells with eosinophilic cytoplasm were associated with necrotic and hemorrhagic tissue (H&E stain,×100). (B) We also noted
neoplastic, pleomorphic cells with high nuclear grade ( H&E stain,×400). The tumor cells had immunoreactivity for synaptophysin (C), CD56 (D),
alpha-inhibin (E), and melan-A (F).
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DISCUSSIONHowever, clinical manifestations in a functional tumor
may result in relatively early detection of a tumor, and it
may be related to a lower incidence of ruptures in functio-
nal ACC than in nonfunctional ACC. It is unknown
whether the cortisol-producing process is related to rup-
tures. Thus, additional investigations to evaluate what is
involved in the rupture of functioning ACC are needed.
A fine needle biopsy is often used for diagnostic pur-
poses in patients with a known extra-adrenal malignancy
who have been shown to have an adrenal mass.
16 The
present patient had a history of primary breast cancer.
However, the fine needle biopsy is not free of compli-
cations. Thus, we did not perform a fine needle biopsy; the
patient had clinical characteristics of cortisol excess, and
there was no evidence of recurring breast cancer. Regard-
ing the association with other tumors, Venkatesh, et al.
17
reported that 13 out of 100 patients with adrenal carcinoma
had a second primary tumor. The most frequent second
primary tumors appeared to be breast carcinoma, thyroid
carcinoma, and melanoma. 
The current patient had a Cushingoid appearance and a
large mass in the left adrenal gland. Endocrine and imag-
ing examination were consistent with Cushing syndrome
due to an ACC. While the patient was waiting for surgery,
she developed left upper quadrant abdominal pain. Imag-
ing studies showed a hemorrhage in the tumor and retro-
peritoneum.
Our case suggests that a spontaneous rupture of an ACC
should be considered in patients who develop abdominal
pain during the diagnostic work-up and in those whose
pain changes, even though a rupture rarely occurs.
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